10 results on '"Garufi S"'
Search Results
2. AF.57 SPOSAB ABP 501: A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501.
3. AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE.
4. PC.01.3 SEVERE ACTIVITY OF INFLAMMATORY BOWEL DISEASE IS A RISK FACTOR FOR SEVERE COVID-19: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD).
5. OC.02.3 A REAL LIFE COMPARISON OF THE EFFECTIVENESS OF ADALIMUMAB VERSUS GOLIMUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS. A MULTICENTRE EXPERIENCE FROM A REGIONAL NETWORK FOR INFLAMMATORY BOWEL DISEASE.
6. P.08.23 WIRELESS CAPSULE ENDOSCOPY IN CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE.
7. P.02.27 SAFETY PROFILE OF ADALIMUMAB THERAPY IN PREGNANCY: A SINGLE CENTER EXPERIENCE.
8. OC.05.3 NERD AND PH CYCLICAL FLUCTUATION: PROPOSED OF THE IDEAL DIAGNOSTIC ALGORITHM.
9. P.06.4 THE ROLE OF SMALL BOWEL CAPSULE ENDOSCOPY IN THE DIAGNOSIS OF CROHN'S DISEASE: A SINGLE CENTRE EXPERIENCE.
10. LIVER STEATOSIS IN END-STAGE RENAL DISEASE PATIENTS ON HAEMODIALYSIS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.